Keyphrases
Phase II Trial
100%
Leukemia Stem Cells
100%
Pediatric Leukemia
100%
Haematopoietic Stem Cell Transplant Recipients
100%
Calfactant
100%
Acute Lung Injury
100%
Patient Demographics
28%
Oxygenation
28%
Improved Outcomes
28%
Specific Intent
14%
Children with Cancer
14%
Subgroup Analysis
14%
Hematopoietic Stem Cell Transplant
14%
Life-threatening Complications
14%
Immunocompromised children
14%
Intratracheal Administration
14%
Pediatric Diseases
14%
Common Life
14%
Intensive Care
14%
All Pediatric
14%
Hospital Stay
14%
Pediatric Population
14%
Ventilation Rate
14%
Medicine and Dentistry
Calfactant
100%
Hematopoietic Stem Cell Transplantation
100%
Pediatrics
100%
Acute Lung Injury
100%
Leukemia
100%
Patient Population
28%
Intratracheal Drug Administration
14%
Pediatric Disease
14%
Malignant Neoplasm
14%
Subgroup Analysis
14%
Artificial Respiration
14%
Intensive Care
14%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Acute Lung Injury
100%
Calfactant
100%
Diseases
14%
Malignant Neoplasm
14%